Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post RHI: Acqn of royalty over Sandstone Gold Project tenements April 28, 2025 Related Posts Albemarle Lifts Lithium Demand Forecast as Energy Storage Surges February 13, 2026 WALKER LANE PROVIDES UPDATE ON LATE FILING OF FINANCIAL STATEMENTS February 13, 2026 RUA GOLD Announces Uplisting to Toronto Stock Exchange February 13, 2026